Traws Pharma, Inc. Machinery and Equipment, Gross
Traws Pharma, Inc. (TRAW) had Machinery and Equipment, Gross of $84.00 thousand as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:MachineryAndEquipmentGross · last filed 2026-04-15
- 2025-12-31: Machinery and Equipment, Gross $84.00K.
- 2025-09-30: Machinery and Equipment, Gross $84.00K.
- 2025-06-30: Machinery and Equipment, Gross $84.00K.
- 2025-03-31: Machinery and Equipment, Gross $84.00K.
| Period end | Machinery and Equipment, Gross |
|---|---|
| 2025-12-31 | $84.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $84.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $84.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $84.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $84.00K 10-K · filed 2026-04-15 |
| 2023-12-31 | $84.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |